RAPT THERAPEUTICS INC (RAPT)
US75382E1091 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -116.80M | -83.84M | -69.20M | -52.89M | -43.00M | |||
| Depreciation Amortization | 1.22M | 1.05M | 1.00M | 1.12M | 1.33M | |||
| Change In Working Capital | 5.50M | -1.34M | -4.30M | 2.34M | 4.13M | |||
| Taxes Paid | N/A | N/A | 0.00 | 990.00K | 660.00K | |||
| Other non cash items | 13.04M | 13.36M | 11.48M | 8.93M | 2.06M | |||
| OPERATING CASH FLOW | -97.05M | -70.77M | -61.03M | -40.49M | -35.47M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -1.13M | -850.00K | -760.00K | -400.00K | -890.00K | |||
| Other Investing Activity | 105.26M | -44.65M | -80.59M | -87.04M | 50.00K | |||
| INVESTING CASH FLOW | 104.13M | -45.49M | -81.35M | -87.44M | -840.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Stock Issued/Repurchased | 1.45M | 131.18M | 141.48M | 75.46M | 49.90M | |||
| FINANCING CASH FLOW | 1.45M | 131.18M | 141.48M | 75.46M | 49.90M | |||
| CHANGE IN CASH | 8.53M | 14.92M | -900.00K | -52.47M | 13.59M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -97.05M | -70.77M | -61.03M | -40.49M | -35.47M | |||
| Capital Expenditure | -1.13M | -850.00K | -760.00K | -400.00K | -890.00K | |||
| FREE CASH FLOW | -98.17M | -71.62M | -61.79M | -40.89M | -36.36M | |||
All data in USD